| Metabolomics of human cerebrospinal fluid identifies signatures of malignant glioma. | |
| | |
MedLine Citation:
|
PMID: 22240505 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cerebrospinal fluid is routinely collected for the diagnosis and monitoring of patients with neurological malignancies. However, little is known as to how its constituents may change in a patient when presented with a malignant glioma. Here, we used a targeted mass-spectrometry based metabolomics platform using selected reaction monitoring with positive/negative switching and profiled the relative levels of over 124 polar metabolites present in patient cerebrospinal fluid. We analyzed the metabolic profiles from 10 patients presenting malignant gliomas and seven control patients that did not present malignancy to test whether a small sample size could provide statistically significant signatures. We carried out multiple unbiased forms of classification using a series of unsupervised techniques and identified metabolic signatures that distinguish malignant glioma patients from the control patients. One subtype identified contained metabolites enriched in citric acid cycle components. Newly diagnosed patients segregated into a different subtype and exhibited low levels of metabolites involved in tryptophan metabolism, which may indicate the absence of an inflammatory signature. Together our results provide the first global assessment of the polar metabolic composition in cerebrospinal fluid that accompanies malignancy, and demonstrate that data obtained from high throughput mass spectrometry technology may have suitable predictive capabilities for the identification of biomarkers and classification of neurological diseases. |
| | |
Authors:
|
Jason W Locasale; Tamar Melman; Susan Song; Xuemei Yang; Kenneth D Swanson; Lewis C Cantley; Eric T Wong; John M Asara |
Related Documents
:
|
13678565 - Mitochondrial dysfunction in sepsis. 3367405 - Identification of novel prognostic indicators in burned patients. 12131395 - Incidence, outcome, and long-term consequences of herpes simplex virus type 1 reactivat... 8435115 - Burn epidemiology: the pink city scene. 19937695 - Severe lactic acidosis during treatment of chronic hepatitis b with entecavir in patien... 18261745 - Madras motor neuron disease (mmnd): clinical description and survival pattern of 116 pa... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2012-01-12 |
Journal Detail:
|
Title: Molecular & cellular proteomics : MCP Volume: 11 ISSN: 1535-9484 ISO Abbreviation: Mol. Cell Proteomics Publication Date: 2012 Jun |
Date Detail:
|
Created Date: 2012-06-13 Completed Date: 2012-10-11 Revised Date: 2013-04-16 |
Medline Journal Info:
|
Nlm Unique ID: 101125647 Medline TA: Mol Cell Proteomics Country: United States |
Other Details:
|
Languages: eng Pagination: M111.014688 Citation Subset: IM |
Affiliation:
|
Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston Massachusetts 02115, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Brain Neoplasms / cerebrospinal fluid*, pathology Case-Control Studies Cluster Analysis Female Glioblastoma / cerebrospinal fluid*, pathology Humans Male Metabolome* Metabolomics Middle Aged Monte Carlo Method Principal Component Analysis Sensitivity and Specificity Tandem Mass Spectrometry Tumor Burden Tumor Markers, Biological / cerebrospinal fluid* |
| Grant Support | |
ID/Acronym/Agency:
|
3P30CA006516-45S7/CA/NCI NIH HHS; NIH P01 CA120964/CA/NCI NIH HHS; NIH R01-GM41890/GM/NIGMS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Tumor Markers, Biological |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic r...
Next Document: Integrated proteomic, transcriptomic, and biological network analysis of breast carcinoma reveals mo...